Acute otitis media severity of symptom score in a tympanocentesis study. Academic Article uri icon


  • METHODS We used the AOM-SOS (see below) to follow-up symptoms of children 6 to 92 months of age with AOM, who were enrolled in a double-tap, phase II, dose-ranging study of faropenem medoxomil, the methods of which have been previously reported. 3 The primary objective of the trail was to compare the bacteriologic efficacy of 4 doses of faropenem medoxomil (7.5, 15, 30, and 40 mg/kg doses); the evaluation of symptoms scores was exploratory. Only data from children who received at least 1 dose of faropenem medoxomil were included.

publication date

  • January 1, 2011